scPharmaceuticals buy BiotechBee
Start price
29.09.22
/
50%
€6.15
Target price
31.12.24
€8.00
Performance (%)
-23.25%
End price
10.10.22
€4.72
Summary
This prediction ended on 10.10.22 with a price of €4.72. The prediction for scPharmaceuticals disappointed with a performance of -23.25%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| scPharmaceuticals | -6.250% | -6.250% | -53.073% |
| iShares Core DAX® | 2.112% | -0.367% | 13.466% |
| iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% |
| iShares Nikkei 225® | -1.555% | -7.320% | 18.451% |
| iShares S&P 500 | -0.472% | -2.078% | 27.488% |
According to BiotechBee what are the pros and cons of scPharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year